Join to View Full Profile
622 W 168th StNew York, NY 10032
Phone+1 774-823-9187
Dr. Siegelin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 2010 - 2013
Goethe University Frankfurt Medical FacultyClass of 2005
Certifications & Licensure
NY State Medical License 2013 - 2026
American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- 12 citationsUsp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.Elena Bianchetti, S.J. Bates, Steven L. Carroll, Markus D. Siegelin, Kevin A. Roth
Scientific Reports. 2018-11-26 - 11 citationsSimultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in VitroGeorg Karpel-Massler, Mike-Andrew Westhoff, Richard E. Kast, Annika Dwucet, S. Karpel-Massler
Neurochemical Research. 2017-03-07 - 93 citationsAdaptive Mitochondrial Reprogramming and Resistance to PI3K TherapyJagadish C. Ghosh, Markus D. Siegelin, Valentina Vaira, Alice Faversani, Michele Tavecchio
Journal of the National Cancer Institute. 2015-03-01
Press Mentions
Velocity Raises More Than $1.1 Million to End CancerNovember 28th, 2022- Three Columbia Physicians Named to American Society for Clinical InvestigationFebruary 14th, 2022
Clinical Cancer Research Article Describes Opportunity to Use Imipridones for Brain TumorsAugust 22nd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
